319 related articles for article (PubMed ID: 19008778)
1. Toll-like receptors in ischemia-reperfusion injury.
Arumugam TV; Okun E; Tang SC; Thundyil J; Taylor SM; Woodruff TM
Shock; 2009 Jul; 32(1):4-16. PubMed ID: 19008778
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.
Wang Y; Abarbanell AM; Herrmann JL; Weil BR; Poynter J; Manukyan MC; Crisostomo PR; Meldrum DR
Shock; 2010 Dec; 34(6):548-57. PubMed ID: 20458266
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors: a novel target for therapeutic intervention in intestinal and hepatic ischemia-reperfusion injury?
Vasileiou I; Kostopanagiotou G; Katsargyris A; Klonaris C; Perrea D; Theocharis S
Expert Opin Ther Targets; 2010 Aug; 14(8):839-53. PubMed ID: 20568914
[TBL] [Abstract][Full Text] [Related]
4. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage.
Mollen KP; Anand RJ; Tsung A; Prince JM; Levy RM; Billiar TR
Shock; 2006 Nov; 26(5):430-7. PubMed ID: 17047512
[TBL] [Abstract][Full Text] [Related]
5. Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease.
Ionita MG; Arslan F; de Kleijn DP; Pasterkamp G
J Innate Immun; 2010; 2(4):307-15. PubMed ID: 20431283
[TBL] [Abstract][Full Text] [Related]
6. The role of Toll-like receptors in non-infectious lung injury.
Jiang D; Liang J; Li Y; Noble PW
Cell Res; 2006 Aug; 16(8):693-701. PubMed ID: 16894359
[TBL] [Abstract][Full Text] [Related]
7. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
van Beijnum JR; Buurman WA; Griffioen AW
Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
[TBL] [Abstract][Full Text] [Related]
8. Contribution of renal tubule epithelial cells in the innate immune response during renal bacterial infections and ischemia-reperfusion injury.
Ben Mkaddem S; Chassin C; Vandewalle A
Chang Gung Med J; 2010; 33(3):225-40. PubMed ID: 20584500
[TBL] [Abstract][Full Text] [Related]
9. Tracking the toll of kidney disease.
Shirali AC; Goldstein DR
J Am Soc Nephrol; 2008 Aug; 19(8):1444-50. PubMed ID: 18579638
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor signaling in liver ischemia and reperfusion.
Chang WJ; Toledo-Pereyra LH
J Invest Surg; 2012 Aug; 25(4):271-7. PubMed ID: 22853814
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory mediators of liver ischemia-reperfusion injury.
Walsh KB; Toledo AH; Rivera-Chavez FA; Lopez-Neblina F; Toledo-Pereyra LH
Exp Clin Transplant; 2009 Jun; 7(2):78-93. PubMed ID: 19715511
[TBL] [Abstract][Full Text] [Related]
12. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation.
Gribar SC; Anand RJ; Sodhi CP; Hackam DJ
J Leukoc Biol; 2008 Mar; 83(3):493-8. PubMed ID: 18160540
[TBL] [Abstract][Full Text] [Related]
13. Activation of the innate immune system by the endogenous ligand hyaluronan.
Shirali AC; Goldstein DR
Curr Opin Organ Transplant; 2008 Feb; 13(1):20-5. PubMed ID: 18660702
[TBL] [Abstract][Full Text] [Related]
14. The role of toll-like receptor-4 in the development of multi-organ failure following traumatic haemorrhagic shock and resuscitation.
McGhan LJ; Jaroszewski DE
Injury; 2012 Feb; 43(2):129-36. PubMed ID: 21689818
[TBL] [Abstract][Full Text] [Related]
15. Chemokines in ischemia and reperfusion.
Frangogiannis NG
Thromb Haemost; 2007 May; 97(5):738-47. PubMed ID: 17479184
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors in inflammation, infection and cancer.
Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
[TBL] [Abstract][Full Text] [Related]
17. Renal Toll-like receptors: recent advances and implications for disease.
El-Achkar TM; Dagher PC
Nat Clin Pract Nephrol; 2006 Oct; 2(10):568-81. PubMed ID: 17003836
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors in autoimmunity.
Fischer M; Ehlers M
Ann N Y Acad Sci; 2008 Nov; 1143():21-34. PubMed ID: 19076342
[TBL] [Abstract][Full Text] [Related]
19. Innate alloimmunity: history and current knowledge.
Land W
Exp Clin Transplant; 2007 Jun; 5(1):575-84. PubMed ID: 17617046
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Fukata M; Vamadevan AS; Abreu MT
Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
